![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » NeuroMetrix Announces Program Relationship With Eli Lilly
NeuroMetrix Announces Program Relationship With Eli Lilly
March 15, 2005
NeuroMetrix, a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, announced that it has joined Eli Lilly in an Education & Development Program to improve awareness and detection of diabetic peripheral neuropathy.
MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqJzR0bKbmdC0yJC1mdm)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct